You have selected the view in English
Descriptor English: | Aminoglutethimide |
Descriptor Spanish: | Aminoglutetimida |
Descriptor Portuguese: | Aminoglutetimida |
Descriptor French: | Aminoglutéthimide |
Entry term(s): |
Cytadren Orimeten |
Tree number(s): |
D03.383.621.808.425.100 |
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000616 |
Scope note: | An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER. |
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
Pharm Action: |
Antineoplastic Agents, Hormonal Aromatase Inhibitors |
Registry Number: | 0O54ZQ14I9 |
CAS Type 1 Name: | 2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl- |
Public MeSH Note: | 73 |
History Note: | 73(66) |
DeCS ID: | 625 |
Unique ID: | D000616 |
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents |
Date Established: | 1973/01/01 |
Date of Entry: | 1999/01/01 |
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Aminoglutethimide
- Preferred
Cytadren
- Narrower
Concept UI |
M0000944 |
Scope note | An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER. |
Preferred term | Aminoglutethimide |
Concept UI |
M0000945 |
Preferred term | Cytadren |
Entry term(s) |
Orimeten |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey